CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 10 years ago You may also like 59:04 Results from Phase I/II HOPE Clinical Trial of CAP-1002 (April 2017) 8 years ago Research & Clinical Trial Webinars,Webinars 45:19 Givinostat in Duchenne (April 2017) 8 years ago Research & Clinical Trial Webinars,Webinars 45:38 Akashi Provides Update on HT-100 (March 2017) 8 years ago Research & Clinical Trial Webinars,Webinars 52:49 Idebenone Clinical Trials in Duchenne (March 2017) 8 years ago Research & Clinical Trial Webinars,Webinars 44:38 NS Pharma’s Exon 53 Skipping Program: Trial Recruitment & Update (February 2017) 8 years ago Research & Clinical Trial Webinars,Webinars 39:37 MoveDMD Trial: Catabasis Provides Update (February 2017) 8 years ago Research & Clinical Trial Webinars,Webinars 41:31 Mission DMD: FibroGen’s Anti-Fibrosis Program (February 2017) 8 years ago Research & Clinical Trial Webinars,Webinars 58:17 Summit’s Utrophin Modulation Program (January 2017) 8 years ago Research & Clinical Trial Webinars,Webinars «1…1718192021…25»Page 19 of 25
by: Parent Project Muscular Dystrophy
